Stockreport

Aclaris Therapeutics Highlights Atopic Dermatitis Data Catalysts, ITK Progress at Leerink Conference [Yahoo! Finance]

Aclaris Therapeutics, Inc.  (ACRS) 
Last aclaris therapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: aclaristx.com
PDF Phase 2 trial for moderate-to-severe atopic dermatitis read out in the back half of the year and ATI-052 (bispecific) showing early PD signals including a claimed "100% [Read more]